Teleflex Announces Fourth Quarter and Full Year 2018 Earnings Conference Call Information

Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, February 21, 2019

WAYNE, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2018 will be released before market open on Thursday, February 21, 2019. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February 21, 2019. The call can be accessed through a live audio webcast on the company’s website, www.teleflex.com. An audio replay of the call will also be available on the website from February 21, 2019 at 11:00 a.m. (ET) to February 26, 2019 at 11:00 a.m. (ET) by calling 855-859-2056 (U.S./Canada) or 404-537-3406 (International), Passcode: 3059948.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190207005042/en/

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836

Source: Teleflex Incorporated

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Utah Medical Products (UTMD) Reports Q1 EPS of $1.10
• Arca Biopharma (ABIO) Reports Q1 Loss of $0.14